225 related articles for article (PubMed ID: 31915695)
1. Possible Effects of Proton Pump Inhibitors on Hearing Loss Development.
Wiciński M; Malinowski B; Puk O; Górski K; Adamkiewicz D; Chojnacki G; Walczak M; Wódkiewicz E; Szambelan M; Adamska P; Skibińska K; Socha M; Słupski M; Pawlak-Osińska K
Biomed Res Int; 2019; 2019():4853695. PubMed ID: 31915695
[TBL] [Abstract][Full Text] [Related]
2. Association between Proton Pump Inhibitors and Hearing Impairment: A Nested Case-Control Study.
Kim SY; Lee CH; Min C; Yoo DM; Choi HG
Curr Issues Mol Biol; 2021 May; 43(1):142-152. PubMed ID: 34070082
[TBL] [Abstract][Full Text] [Related]
3. Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memory.
Makunts T; Alpatty S; Lee KC; Atayee RS; Abagyan R
Sci Rep; 2019 Nov; 9(1):17280. PubMed ID: 31754136
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitor use and hearing loss in patients with type 2 diabetes: Evidence from a hospital-based case-control study and a population-based cohort study.
Yee J; Han HW; Gwak HS
Br J Clin Pharmacol; 2022 Jun; 88(6):2738-2746. PubMed ID: 34970788
[TBL] [Abstract][Full Text] [Related]
5. How May Proton Pump Inhibitors Impair Cardiovascular Health?
Sukhovershin RA; Cooke JP
Am J Cardiovasc Drugs; 2016 Jun; 16(3):153-61. PubMed ID: 26817947
[TBL] [Abstract][Full Text] [Related]
6. Prolonged utilization of proton pump inhibitors in patients with ischemic and valvular heart disease is associated with surgical treatments, weight loss and aggravates anemia.
Boban M; Zulj M; Persic V; Medved I; Zekanovic D; Vcev A
Int J Cardiol; 2016 Sep; 219():277-81. PubMed ID: 27343420
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular and non-cardiovascular concerns with proton pump inhibitors: Are they safe?
Corsonello A; Lattanzio F
Trends Cardiovasc Med; 2019 Aug; 29(6):353-360. PubMed ID: 30389278
[TBL] [Abstract][Full Text] [Related]
8. Community-dwelling older adults' awareness of the inappropriate use of proton pump inhibitors.
Rababa M; Rababa'h A
BMC Geriatr; 2020 Oct; 20(1):431. PubMed ID: 33121444
[TBL] [Abstract][Full Text] [Related]
9. Proton Pump Inhibitors, Associated Complications, and Alternative Therapies: A Shifting Risk Benefit Ratio.
Friedman AJ; Elseth AJ; Brockmeyer JR
Am Surg; 2022 Jan; 88(1):20-27. PubMed ID: 33560890
[TBL] [Abstract][Full Text] [Related]
10. Side Effects of Proton Pump Inhibitors: What are Patients' Concerns?
Rameau A; Andreadis K; Bayoumi A; Kaufman M; Belafsky P
J Voice; 2021 Sep; 35(5):809.e15-809.e20. PubMed ID: 32093923
[TBL] [Abstract][Full Text] [Related]
11. [Long-term use of proton pump inhibitors: who needs prophylaxis?].
Scheurlen M
Internist (Berl); 2013 Mar; 54(3):366-72. PubMed ID: 23404267
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of hangeshashinto for treatment of GERD refractory to proton pump inhibitors : Usual dose proton pump inhibitors plus hangeshashinto versus double-dose proton pump inhibitors: randomized, multicenter open label exploratory study.
Takeuchi T; Hongo H; Kimura T; Kojima Y; Harada S; Ota K; Takeuchi N; Noguchi T; Inoue T; Murano M; Higuchi K
J Gastroenterol; 2019 Nov; 54(11):972-983. PubMed ID: 31037449
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitor therapy and potential long-term harm.
Corleto VD; Festa S; Di Giulio E; Annibale B
Curr Opin Endocrinol Diabetes Obes; 2014 Feb; 21(1):3-8. PubMed ID: 24310148
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events.
Fortuna LA; Pawloski PA; Parker ED; Trower NK; Kottke TE
Eur Heart J Cardiovasc Pharmacother; 2016 Jan; 2(1):13-9. PubMed ID: 27533057
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitors are associated with increased risk of development of chronic kidney disease.
Arora P; Gupta A; Golzy M; Patel N; Carter RL; Jalal K; Lohr JW
BMC Nephrol; 2016 Aug; 17(1):112. PubMed ID: 27487959
[TBL] [Abstract][Full Text] [Related]
16. Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.
Lee L; Ramos-Alvarez I; Ito T; Jensen RT
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31623145
[TBL] [Abstract][Full Text] [Related]
17. Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids-What Is the Relationship?
McCarthy DM
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963924
[TBL] [Abstract][Full Text] [Related]
18. Effects on the cost and utilization of proton pump inhibitors from adding over-the counter omeprazole to drug benefit coverage in a state employee health plan.
Harris BN; West DS; Johnson J; Hong SH; Stowe CD
J Manag Care Pharm; 2004; 10(5):449-55. PubMed ID: 15369428
[TBL] [Abstract][Full Text] [Related]
19. Long-term continuous use of proton-pump inhibitors is associated with renal function decline in patients without acute kidney injury.
Hatakeyama Y; Horino T; Matsumoto T; Terada Y; Okuhara Y
Clin Exp Nephrol; 2021 Oct; 25(10):1087-1092. PubMed ID: 34089392
[TBL] [Abstract][Full Text] [Related]
20. [Hypersensitivity to proton pump inhibitors].
Bergmann M; Guignard B; Ribi C
Rev Med Suisse; 2012 Apr; 8(337):830-5. PubMed ID: 22594006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
